Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3077 |
|
Actual shortage: | 235 (8%) | |
Anticipated shortage: | 16 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2817 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2021-12-17 | 2022-03-29 | 151345 |
APO-TADALAFIL | 2.5MG | TABLET | Resolved | 2022-03-11 | 2022-04-01 | 156555 |
APO-DESVENLAFAXINE | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-03-25 | 2022-04-01 | 157298 |
APO-TRAVOPROST-TIMOP PQ | 0.004% 0.5% | SOLUTION | Resolved | 2020-09-30 | 2022-04-01 | 125361 |
FLUCONAZOLE 150 | 150MG | CAPSULE | Resolved | 2022-02-11 | 2022-04-01 | 154746 |
APO-AMLODIPINE-ATORVASTATIN | 80MG 10MG | TABLET | Resolved | 2022-03-18 | 2022-04-01 | 156983 |
APO-AMLODIPINE-ATORVASTATIN | 20MG 10MG | TABLET | Resolved | 2022-02-18 | 2022-04-01 | 155308 |
APO-COLESEVELAM | 625MG | TABLET | Resolved | 2022-03-11 | 2022-04-01 | 156537 |
APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2022-01-21 | 2022-04-01 | 153262 |
APO-CETIRIZINE | 20MG | TABLET | Resolved | 2022-02-18 | 2022-04-01 | 155311 |
APO-AMLODIPINE-ATORVASTATIN | 80MG 5MG | TABLET | Resolved | 2022-02-04 | 2022-04-01 | 154168 |
APO-ATOMOXETINE | 60MG | CAPSULE | Resolved | 2022-02-25 | 2022-04-01 | 155600 |
ANAFRANIL | 25MG | TABLET | Resolved | 2022-03-18 | 2022-04-04 | 156980 |
APO-CILAZAPRIL | 5MG | TABLET | Resolved | 2021-12-24 | 2022-04-04 | 151883 |
APO-DESVENLAFAXINE | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-03-18 | 2022-04-06 | 156987 |
APO-QUETIAPINE XR | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-03-11 | 2022-04-06 | 156543 |
APO-QUETIAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-03-11 | 2022-04-06 | 156546 |
APO-QUETIAPINE XR | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-03-11 | 2022-04-06 | 156549 |
APO-TADALAFIL | 20MG | TABLET | Resolved | 2022-02-18 | 2022-04-08 | 155324 |
APO-ROSUVASTATIN | 40MG | TABLET | Resolved | 2022-03-25 | 2022-04-11 | 157329 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60735 | ||
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60738 | ||
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60747 |
APO-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60775 |
APO-SERTRALINE | 100MG | CAPSULE | Discontinued | 2018-09-08 | 2018-09-15 | 60781 |
APO-SILDENAFIL | 100MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60784 |
APO-SILDENAFIL R | Discontinued | 2018-09-08 | 2018-09-15 | 60787 | ||
APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40811 |
APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40814 |
APO-SUCRALFATE - TAB 1G | 1G | TABLET | Discontinued | 2018-09-10 | 2018-09-15 | 61033 |
APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40817 |
APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40820 |
APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40823 |
APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40826 |
APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60831 |
APO-TRAZODONE TABLETS 50MG | 50MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60834 |
APO-VALACYCLOVIR | 500MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60840 |
APO-VALGANCICLOVIR | 450MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60843 |
APO-VORICONAZOLE | 200MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60858 |